Four binuclear phosphanesilver(I) dithiocarbamates, {cyclohexyl 3 PAg(S 2 CNRR′)} 2 for R = R′ = Et (1), CH 2 CH 2 (2), CH 2 CH 2 OH (3) and R = Me, R′ = CH 2 CH 2 OH (4) have been synthesised and characterised by spectroscopy and crystallography, and feature tri-connective, μ 2 -bridging dithiocarbamate ligands and distorted tetrahedral geometries based on PS 3 donor sets. The compounds were evaluated for anti-bacterial activity against a total of 12 clinically important pathogens. Based on minimum inhibitory concentration (MIC) and cell viability tests (human embryonic kidney cells, HEK 293), 1-4 are specifically active against Gram-positive bacteria while demonstrating low toxicity; 3 and 4 are active against methicillin resistant S. aureus (MRSA). Across the series, 4 was most effective and was more active than the standard anti-biotic chloramphenicol. Time kill assays reveal 1-4 to exhibit both time-and concentration-dependent pharmacokinetics against susceptible bacteria. Compound 4 demonstrates rapid (within 2 h) bactericidal activity at 1 and 2 × MIC to reach a maximum decrease of 5.2 log 10 CFU/mL against S. aureus (MRSA).
Introduction
The inexorable emergence of anti-biotic resistant bacteria to multiple anti-bacterial agents is now recognised as a significant global health threat worldwide as there are fewer or even no effective antibiotic treatments available for these infectious pathogens [1] . The problem arises in part due to selective stress exerted on bacteria that is driven by the use and misuse of anti-bacterial agents in food producing animals and patients. This pressure has forced the quickly replicating bacteria to develop resistance mechanisms [2, 3] . This worrying situation highlights the urgent need to develop novel and selective antibacterial drugs. The real challenge remains to develop new anti-bacterial agents with new mechanisms of action that can overcome acquired resistance without contributing to resistance development [4] .
Historically, metal-based drugs have been used as drugs to treat a variety of diseases, i.e. platinum compounds, e.g. cisplatin, carboplatin and oxaliplatin, are the most widely used cancer therapeutic agents, and gold compounds, e.g. myocrisin and auranofin, are used for the treatment of rheumatoid arthritis [5] . Notably, silver and its compounds [6, 7] and silver-based nanoparticles [8] have long been known to possess strong inhibitory and bactericidal effects as well as a broad spectrum of anti-microbial activities for bacteria, fungi and viruses, and continue to attract significant attention [9] [10] [11] [12] . Silver generally exhibits higher toxicity to microorganisms with lower toxicity to mammalian cells compared with other metals [13] .
Recent studies have highlighted metal dithiocarbamate derivatives, M y (S 2 CNRR′) y , as potential metal-based drugs to combat bacterial infection [14] . Thus, over the years, various transition metal complexes [15] [16] [17] and main group element dithiocarbamate compounds [18] [19] [20] [21] have been investigated in this context and interest continues with a focus of recent research being upon coinage metal dithiocarbamates, i.e. of copper(I) and silver(I) [22] and of gold(I) [23, 24] . In the latter studies, emphasis has moved away from R, R′ = alkyl compounds to include hydroxyethyl substituents owing to the possibility of enhanced hydrophilicity of the resultant compounds. Noteworthy results from these previous biological assays include the observation that the antibacterial activity of a series phosphanegold(I) dithiocarbamates, R 3 PAu [S 2 CN(iPr)CH 2 CH 2 OH] for R = Et, cyclohexyl (Cy) and Ph, were found to be dependent on the nature of the phosphane-bound substituent. While the R = Cy and Ph derivatives exhibited specific activity against Gram-positive bacteria, the R = Et compound showed broad range activity against both Gram-positive and Gram-negative bacteria [23] .
bacteriostatic depending on the specific bacterial strain investigated [23] . In a latter study, a series of bis(triphenylphosphane)-copper (I) and -silver(I) dithiocarbamates were investigated as new anti-bacterial agents and revealed activities dependent upon both phosphane-and dithiocarbamate-bound substituents [22] . Reflecting the interesting results obtained for the ternary phosphane-copper (I) and silver(I) dithiocarbamate compounds in tackling pathogens and in recognition of the potential of silver dithiocarbamates as effective anti-bacterial agents, the preceding studies were extended to the four compounds shown in Fig. 1 , i.e. containing tricyclohexylphosphane co-ligands. Herein, a study was conducted to determine the efficacy of 1-4 as potential anti-bacterial agents against a range of Gram-positive and Gram-negative bacteria using disc diffusion, MIC and MBC assays. To further determine the preliminary pharmacokinetics of these complexes, time kill assays were employed to assess whether the treated bacteria were bactericidal or bacteriostatic. The cytotoxicity effects of 1-4 were evaluated through a MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay on normal cells, i.e. HEK 293 human embryonic kidney epithelial cells.
Experimental

Materials
All chemicals and solvents were used as received. Reactions were carried out under ambient conditions. The sodium diethyldithiocarbamate trihydrate (BDH Chemicals) and ammonium pyrrolidinedithiocarbamate (Sigma-Aldrich), tricyclohexylphosphane (Cy 3 P; SigmaAldrich) and AgNO 3 (Systerm) were obtained from commercial sources. The hydroxyethyl dithiocarbamate ligands, − S 2 CN(R)CH 2 CH 2 OH for R = CH 2 CH 2 OH and Me, as K + or NH 4 + salts, were prepared as per an earlier study [25] .
Instrumentation
Melting points were determined on an Automatic Melting Apparatus MP450 (Biobase, China). Elemental analyses were performed on a Leco TruSpec Micro CHN Elemental Analyser. IR spectra were obtained on a Vertex 70v FTIR Spectrometer (Bruker, Germany); abbreviations: s = strong; m = medium. 
Bis{tricyclohexylphosphanesilver(I) N,N-pyrrolidinedithiocarbamate} (2)
Compound 2 was prepared as for 1 but using NH 4 
Bis{tricyclohexylphosphanesilver(I) N,N-dihydroxyethyldithio carbamate} (3)
The compound was prepared from the in situ reaction of AgNO 3 , Cy 3 P and K[S 2 CN(CH 2 CH 2 OH) 2 ] in a 1:1:1 ratio. AgNO 3 (1 mmol; 0.170 g) was stirred with Cy 3 P (1 mmol; 0.280 g) in acetonitrile (10 mL) at room temperature to obtain a suspension. To this K[S 2 CN (CH 2 CH 2 OH) 2 ] (1 mmol; 0.219 g) in water (4 mL)/ethanol (6 mL) mixture was added followed by stirring for 2 h. Chloroform (20 mL) was added and stirring was continued for another 2 h, after which the yellow chloroform solution was separated. The organic solution was dried over MgSO 4 , filtered and slowly evaporated to yield a brightyellow gel. A minimum volume of hexane (2 mL) was added to this gel while stirring vigorously until precipitation occurred. The yellow precipitates were isolated through filtration. Recrystallization was performed in methanol via slow evaporation, yielding yellow block crystals. Yield: 60%. M. 
Bis{tricyclohexylphosphanesilver(I) N-hydroxyethyl-N-methyldithio carbamate} (4)
AgNO 3 (1 mmol; 0.170 g) was stirred with Cy 3 P (1 mmol; 0.280 g) in acetonitrile (10 mL) at room temperature to yield a suspension. Then, 
Single crystal X-ray structure determinations
Intensity data for 1-4 were measured at 100 K on an Rigaku/Oxford Diffraction XtaLAB Synergy diffractometer (Dualflex, AtlasS2) using CuKα radiation (λ = 1.54178 Å). Data reduction and Gaussian absorption corrections were by standard methods [26] . The structures were solved by direct methods [27] and refined on F 2 with anisotropic displacement parameters and C-bound H atoms in the riding model approximation [28] . (14) ; no evidence for other disordered atoms was found. The maximum and minimum residual electron density peaks of 1.15 and 0.61 eÅ −3 , respectively, were located 0.87 and 0.39 Å from the C18 and H23a atoms, respectively. In the refinement of 4, the C11-cyclohexyl ring was disordered over two positions. Anisotropic refinement but, with the displacement ellipsoids constrained to be nearly isotropic, led to a site occupancy factor = 0.571(11) for the major component. The maximum and minimum residual electron density peaks of 1.15 and 1.32 eÅ −3 , respectively, were located 0.98 and 0.75 Å from the H26c and Ag1 atoms, respectively. Crystal data and refinement details are collected in Table 1 . The molecular structure diagrams showing 70% probability displacement ellipsoids were generated by ORTEP for Windows [29] and the packing diagrams with DIAMOND [30] . Additional data analysis was made with PLATON [31] . 
Disc diffusion
The disc diffusion method was used to screen for anti-bacterial activity of the synthesised compounds in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines. An inoculum suspension of each bacterial strain was prepared by adjusting the overnight bacterial culture to 0.5 McFarland turbidity standard, corresponding to approximately 10 8 colony forming units CFU/mL. The inoculum was swabbed on the surface of Mueller-Hinton agar (MHA) (Oxoid) plates using a sterile cotton swab. The test compounds were taken up in dimethylsulphoxide (DMSO; Merck) to achieve a test concentration of 2 mg/mL; 1 and 2 were suspensions. Sterile 6 mm filter paper discs were aseptically placed on MHA surfaces and 5 μL of the dissolved test compound was added to the discs, making the total amount of trial compound 10 μg/disc. Each plate contained two different types of standard anti-biotic paper discs, chloramphenicol (30 μg/disc) and tetracycline (30 μg/disc), which served as positive controls, one disc served as the negative control (5 μL MHB), one disc served as solvent control (5 μL DMSO) and two discs were used to evaluate the antibacterial property of the trial compound. The plates were incubated for 24 h at 37°C. The anti-bacterial activity was evaluated by measuring the diameter of inhibition zones. Each experiment was performed in triplicate.
Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)
A broth micro-dilution method was used to determine the MIC and MBC values of the test compounds using CLSI protocols. Each test compound (5 μL) was added into the wells of a 96-well microplate containing 10 5 CFU/mL exponentially growing bacterial cells. The 96-well microplates were incubated at 37°C for 24 h. The final tested concentrations ranged from 0.045 to 100 mg/mL. All tests were performed in triplicate. Four controls comprising medium with standard anti-biotics, chloramphenicol and tetracycline (positive control), medium with DMSO (solvent control), medium with inoculum bacterial cells (negative control) and medium with broth only (negative growth control) were included in each test. As an indicator of bacterial growth, 50 μL of 0.2 mg/mL p-iodonitrotetrazolium violet (Sigma-Aldrich) was added into each well; the presence of bacterial activity will convert the dye from colourless to purple. The microplates were further incubated for at least 30 min under aerobic agitation. The MIC was determined as the lowest concentration at which there is no trace of purple. After MIC determination, an aliquot of 100 μL from each well which showed no visible growth was spread onto MHA and further incubated at 37°C for 24 h. The MBC was defined as the lowest concentration of the tested compound that produced a 99.9% reduction in bacterial viable count on MHA.
Time-kill assay
Time-kill assays were performed using the broth macro-dilution method in accordance with the CLSI guidelines. bactericidal activity, is defined as a reduction of ≥3 log 10 (CFU/mL) relative to the initial inoculum, whereas the bacteriostatic activity corresponds to < 3 log 10 (CFU/mL) decrease relative to the initial inoculum.
Cell viability assay
The cytotoxicity effects of the test compounds were evaluated using a normal cell line, i.e. human embryonic kidney cells (HEK 293). The HEK 293 cells were seeded in a 96-well plate with a density of 1 × 10 5 cells to a final volume of 100 μL per well. The test compounds were prepared by dissolution in DMSO to a concentration of 12 mg/mL, further diluted in Roswell Park Memorial Institute (RPMI)-1640 medium and then added to the well to obtain a final concentration of 0 (untreated control), 0.2, 0.4, 0.6, 0.8, 1 and 0.12 mg/mL. The treated HEK 293 cells were then incubated for 24 h. To investigate the cytotoxicity value of the test compounds, 20 μL of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) solution (5 mg/ mL in phosphate-buffered saline (PBS)) was added to each well and the plate was further incubated for 4 h at 37°C. Prior to analysis, the medium was discarded and replaced with DMSO to dissolve the formazan crystals (i.e. the reduced form of MTT, (E/Z)-5-[4,5-dimethylthiazole-2-yl]-1,3-diphenylformazan) that had formed. The absorbance was measured at 570 nm through microplate reader (Tecan Infinite-M200). The 50% inhibitory concentration (IC 50 ) of each test compound was determined by plotting the graph of percentage of surviving cells against the concentration of the test compound. The assay was performed in triplicate.
Results and discussion
Chemistry and X-ray crystallography
The bis{tricyclohexylphosphanesilver(I) dithiocarbamate} compounds, 1-4, Fig. 1 , were prepared in good yield employing the metathesis reaction between AgNO 3 and the respective dithiocarbamate salt in the presence of Cy 3 P. The colourless compounds are air-and light-stable for at least a month; spectroscopic data are collated in Section 2.3. The IR spectra featured the anticipated bands due to ν(CeN) and ν(CeS) of the dithiocarbamate ligands. The expected resonances and integration were observed in the 1 Ag nuclei. The J P-Ag coupling constants for 1-4 are in close agreement with those reported for related phosphanesilver(I) complexes [32] . The stabilities of 1-4 were monitored by 31 P{ 1 H} NMR. Compounds 1 and 2 were not particularly soluble in d 6 -DMSO and hence, their stability over time could not be reliably determined in this medium. By contrast, 3 and 4 were stable in d 6 -DMSO solution for at least three days. Additional stability experiments were performed in CDCl 3 solution, again using 31 P{ 1 H} NMR. While 1 was stable for at least three days, some decomposition and precipitation was evident for 2-4 after the egress of time with the most noteworthy feature being the appearance of a resonance due to tricyclohexylphosphane oxide (Cy 3 P]O) at approximately 50 ppm. Based on integration, approximately 5-10% decomposition had occurred after 24 h; spectra are given in Supplementary materials Fig. S1 .
Crystals suitable for X-ray crystallography were obtained for 1-4. The molecular structure of 1, is located about a centre of inversion, is shown in Fig. 2a . The structure features a μ 2 -bridging dithiocarbamate ligand whereby the S1 atom bridges two silver(I) centres with disparate AgeS1 bond lengths of 2.5781(3) and 2.8334(3) Å, and with the S2 atom [2.5976(3) Å] closes a four-membered AgS 2 C chelate ring. The participation of the S1 atom in two AgeS bonds results in an elongation in the C1eS1 bond compared with the C1eS2 bond, i.e. 1.7333(13) vs 1.7136(13) Å. The four-coordinate geometry for silver is completed by the phosphane-P atom which forms the shortest of the four bonds to silver [2.4148(3) Å]. The PS 3 donor set is highly disordered with the angles ranging from an acute 66.585(9)°for the S1eAgeS2 chelate angle to a wide 121.668(11)°for S1eAgeP1. The Ag 2 C 2 S 4 atoms have the arrangement of a step ladder, with the chelate rings lying above and below the central Ag 2 S 2 rectangle. Finally, the transannular Ag⋯Ag separation is 2.96470(19) Å.
The molecule in 2, which lacks the crystallographic symmetry of 1, is shown in Fig. 2b ; selected interatomic parameters are given in the figure caption. In 2, a major structural reorganisation has occurred in that the dithiocarbamate ligands lie to the same side of the central Table 1 Crystal data and refinement details for 1-4. The molecular structure of centrosymmetric 3 follows that established for 1, Fig. 2c , including the variations in the AgeS and CeS bond lengths, and Ag⋯Ag separation. Similarly, the range of angles subtended at the Ag atom follow that observed in 1, i.e. the chelate angle [55.109(11) °] is the most acute and the S1eAgeP1 angle is the widest at 125.646(13)°. The final structure to be described is that of 4 for which the crystallographic asymmetric unit comprises two independent centrosymmetric molecules, i.e. two half molecules, Fig. 2d and Supplementary materials Fig. S2 . Each of the independent molecules adopts the same structural motif as found for 1 and 3. The trends in the bond lengths also follow those established above. A distinction between the molecules is found in the tetrahedral angles. While the trend in tetrahedral angles for the Ag1-containing molecule follow those seen for 1 and 3, for the Ag2-molecule, the S3eAg2eP2 and S4eAg2eP2 are very similar, both being approximately 122°.
The molecular packing of 1 features cyclohexyl-methylene-CeH⋯S (dithiocarbamate) interactions whereby adjacent methylene-H atoms of a cyclohexyl ring bridge sulphur atoms derived from two different dithiocarbamate ligands of an adjacent binuclear molecule. These interactions lead to a supramolecular chain aligned along [1 0 0], Fig. 3a ; chains pack without directional interactions between them, Supplementary materials Fig. S3 ; details of the geometric parameters characterising the interatomic parameters are given in the relevant figure captions of the Supplementary materials.
The only interaction between molecules identified within the standard distance criteria assumed in PLATON [31] , is a CeH⋯π(chelate ring) interaction. Such CeH⋯π(chelate ring) interactions are now well known in the supramolecular chemistry of metal complexes, including those of dithiocarbamates, owing to the high delocalisation of π-electron density in the MS 2 C chelate rings formed by dithiocarbamate ligands [33] [34] [35] . As illustrated in Fig. 3b , the CeH⋯π(chelate ring) interactions connect binuclear molecules into a supramolecular dimer; . In the crystal of 4, rather than hydroxylOeH⋯O(hydroxyl) hydrogen bonds, hydroxyl-OeH⋯S(dithiocarbamate) hydrogen bonds are formed instead. As shown in Fig. 3d and Supplementary materials S6a, these sustain centrosymmetric 14-membered {⋯HOC 2 NCS} 2 synthons which alternate with the Ag 2 C 2 S 4 rings along the a-axis and, at the same time contribute to much larger 50-membered {⋯SAgS⋯HOC 2 NCS⋯HOC 2 NCSAgSCNC 2 OH} 2 synthons incorporating six hydroxyl-OeH⋯S(dithiocarbamate) hydrogen bonds and aligned along the c-axis. The resulting supramolecular layers stack along the b-axis without directional interactions between them Supplementary materials Fig. S6b .
An evaluation of the Cambridge Structural Database (CSD) [36] indicates there are seven structures available in the literature of the general formula [R 3 PAg(S 2 CNRR′)] 2 for R, R′, R″ = alkyl or aryl. There are no literature precedents with Cy 3 P as the phosphane ligand nor one with pyrrolidinedithiocarbamate. It is noted that each of the known structures [37] [38] [39] [40] [41] adopts the step-ladder structural motif as described above for 1, 3 and 4. Interestingly, there are four structures of the analogous copper(I) derivatives. Consistent with the above, each of the binuclear structures of [R 3 PCu(S 2 CNEt 2 )] 2 for R = Me, Et and OMe [42] is centrosymmetric implying a step-ladder motif. However, the recently described structure of {Cy 3 PCu[S 2 CN(CH 2 ) 4 ]} 2 [43] , i.e. directly analogous to 2, adopts the same boat form as for 2. Clearly, systematic structural studies are required to ascertain the reason(s), e.g. steric and/or electronic, for these structural variations.
In terms of related structures with tetrahedrally-coordinated silver within a PS 3 donor set, there are over 100 examples included in the CSD [36] . However, there is only a sole example having Cy 3 P as the phosphane ligand, namely Cy 3 PAg[(phenyl-tris(3-methyl-2-thioxoimidazol-1-yl)borate-S,S′,S″)] [44] . In this structure, with two independent molecules in the asymmetric unit, the AgeP bond lengths are experimentally equivalent at 2.3958(7) and 2.3980(7) Å, whereas the AueS bond lengths span a range 2.5692(8) to 2.6530(9) Å. In the structures of 1, 3 and 4, where the central ring adopts the conformation of a stepladder, the AgeP bond lengths are systematically longer and the AgeS bond lengths span a greater range that the literature structure, observations traced to the steric crowding in the molecules. For 2, the AgeP bond length is marginally shorter than those in the literature structure and the AgeS bond lengths span a similar range of values.
Anti-bacterial activity
For all biological trials, only freshly prepared solutions were used. The Kirby-Bauer disc diffusion method was used in the initial screening for the anti-bacterial properties of dithiocarbamate ligands, 1-4, AgNO 3 and standards ( Table 2 ). The solvent used in this study, i.e. DMSO, did not produce an inhibition zone, suggesting DMSO does not exert antibacterial effects on the tested bacterial strains. The results also showed that the − S 2 CNR(CH 2 CH 2 OH) anions, for R = CH 2 CH 2 OH and Me, do not have anti-bacterial activity against the tested bacterial strains while the − S 2 CNEt 2 anion showed low activity, having an effect on only one Gram-positive bacterium (S. epidermidis), but not Gram-negative bacteria. By contrast, the − S 2 CN(CH 2 ) 4 anion was mildly active against all Gram-positive bacteria and one Gram-negative bacteria (K. pneumoniae ATCC 13883).
Enhanced anti-Gram positive bacterial activity was observed when each of the dithiocarbamate anions were incorporated in the silver compounds, 1-4; 1-4 exhibited no activity against Gram-negative bacteria. Comparing the R = alkyl species, 1 and 2, 2 tends to be marginally more potent than 1 exhibiting anti-bacterial effects against all Gram positive bacteria, except for S. aureus (MRSA). The differences in potency exhibited by 1-4 against the Gram-positive bacteria were generally small with the exception against S. pyogenes. S. pyogenes, an α-haemolytic bacterium implicated in Streptococcal pharyngitis, also known as Strep Throat, appeared to be the most susceptible among the tested clinically important Gram-positive bacteria [45] . Despite S. pyogenes being an important medical pathogen, its biology, such as integrity of cell wall, the presence of efflux pumps (that can pump out anti-bacterial agents), etc. is not well documented [45] so the apparent enhanced efficacy of 1-4 is of interest and worthy of further investigation. Compared with 1 and 2, the derivatives with CH 2 CH 2 OH substituents were generally more potent with 3 being the most active among the series against S. pneumoniae (9 mm) and 4 being most potent against both S. pyogenes (12 mm) and S. epidermidis (10 mm). Crucially, both 3 and 4 exhibit anti-bacterial activity against S. aureus (MRSA) with inhibition zones of 9 and 7 mm, respectively.
The disc diffusion results demonstrated that compounds 1-4 were specifically effective against Gram-positive bacteria but not Gram-negative bacteria. The selective activity against only Gram-positive bacteria leads to the speculation that the permeability barrier of the outer membrane present in Gram-negative bacteria limits the entry of compounds 1-4. The Gram-negative cell outer membrane contains lipopolysaccharides in its outer leaflet and phospholipid in its inner leaflet that are known to effectively exclude several drugs compared to Grampositive bacteria [46] . Similar anti-bacterial selectivity effects were observed for the previously studied silver, copper and gold dithiocarbamates [22] [23] [24] .
Trials were also conducted on AgNO 3 . It is interesting to note that AgNO 3 was non-specific in terms of inhibiting Gram-positive and Gramnegative bacteria indicating the presence of the dithiocarbamate ligands in 1-4 introduces specificity in activity. The clinically-employed anti-biotics chloramphenicol and tetracycline (each 30 μg/disc) were included in this study as controls. These drugs produced respectively, large inhibition zones of 30-39 and 28-38 mm against Gram-positive bacteria, and 10-28 and 11-31 mm against Gram-negative, Table 2 . These differences in activity against Gram-positive bacteria are largely due to the lower concentrations employed for 1-4 (10 μg).
Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)
The disc diffusion assay showed that two of the dithiocarbamate anions and 1-4 exhibited anti-bacterial activity. This activity was further quantitatively evaluated against Gram positive bacteria by determining their MIC and MBC values with the results tabulated in Table 3 ; the anti-biotics tetracycline and chloramphenicol were used as positive controls.
In this study, 4 , MIC values ranging from 12.5 to 50.0 μg/mL were observed for all Gram-positive bacteria. The antibacterial effects of 1-4 were maintained or enhanced when compared to their respective anions, except for 2 on S. aureus (MRSA). The enhanced inhibitory effects of 1-4 compared to the (charged) dithiocarbamates might be due to an increase in the lipophilicity of (neutral) 1-4 [47, 48] . The MIC values of 1-4 were in the range of 0.10-100 μg/ mL, whereas tetracycline was active in the range of 0.20-0.39 μg/mL and chloramphenicol in the range of 1.56 to 6.25 μg/mL.
As a general observation, the MIC values of 3 and 4 against all tested Gram-positive bacteria were lower than for 1 and 2, and significantly lower than those produced by AgNO 3 . Compound 3 was effective in inhibiting the growth of all tested Gram-positive bacteria with MIC values in the range of 0.39 (S. epidermidis and S. pneumoniae) to 3.13 μg/mL (S. aureus (MRSA)). Compound 4 was the most effective compound across the series, being most potent against S. epidermidis with a MIC value of 0.10 μg/mL. It was also the most active against S. pneumoniae (MIC = 0.20 μg/mL), E. faecalis (0.78 μg/mL), S. pyogenes (0.78 μg/mL) and S. aureus (MRSA) (1.56 μg/mL).
It was initially expected that 3, Cy 3 PAg[S 2 CN(CH 2 CH 2 OH) 2 ], with two hydroxyethyl groups, would be the most effective anti-bacterial agent as the second hydroxyethyl functional group might allow for the formation of additional hydrogen bonding interactions with biological substrates, leading to the impairment of normal cellular processes in bacterial cells [49] . However, the results showed 4, Cy 3 PAg[S 2 CN (Me)CH 2 CH 2 OH], with a less polar group (methyl), was most active. It is possible that the increased lipophilic character of 4 enables more efficient diffusion across the membrane into the cytoplasm of bacterial cells, before exhibiting its anti-bacterial effects [50] .
Previous studies on a related gold(I) species, i.e. Cy 3 PAu[S 2 CN (CH 2 CH 2 OH) 2 ], gave MIC values in the range of 1.56-50.00 μg/mL against all tested Gram-positive bacteria [24] . In the present study, the MIC values obtained for compound 3, {Cy 3 PAg[S 2 CN(CH 2 CH 2 OH) 2 } 2 were relatively lower than the MIC values for the aforementioned gold derivative. This, coupled with observation that replacing one hydroxyethyl with a methyl group to yield 4 further enhanced the anti-bacterial activity, indicate that the new silver dithiocarbamates described herein are potential potent anti-bacterial agents.
Given that inhibition of bacterial growth does not necessarily indicate the ability of a test compound to kill a particular bacterium, the minimum bactericidal concentration (MBC) was determined to identify whether the test compound was able to kill a bacterium (bactericidal) or only inhibited growth (bacteriostatic). Both bactericidal and bacteriostatic anti-biotics are used to treat a variety of bacterial infections. Bactericidal anti-biotics can be taken for a short period of time and are often used to reduce the risk/cure the infection better than bacteriostatic anti-biotics. It is noted that bacteriostatic anti-biotics are often sufficient to treat an infection by slowing the growth of the bacteria while the individual's immune system fights/eliminates the infection. However, the infection may persist if a patient is immunocompromised [51, 52] . The knowledge on the use of either bactericidal or bacteriostatic agents is crucial for the effective treatment of an infected patient. With this in mind, the bactericidal or bacteriostatic properties of 1-4 were investigated.
The generally accepted definition of MBC by Levison [53] is used herein: an anti-bacterial agent is considered bactericidal if the value of MBC is not more than four-fold greater than the MIC, i.e. MBC/ MIC ≤ 4. The anti-bacterial properties of 1-4 against susceptible strains were analysed by the MBC assay and the results are summarised as MBC/MIC ratios in Table 3 . For the chosen Gram-positive bacteria, chloramphenicol (see below) and tetracycline were bacteriostatic. While AgNO 3 was bactericidal against all tested bacteria, this is not potent. For compounds 1 and 2, bactericidal activity was proven against S. pyogenes and S. epidermidis. Compounds 3 and 4 were shown to be bactericidal (MBC/MIC ≤ 2) toward all the susceptible Grampositive strains, except against S. pneumoniae, with the MBC being 16-fold greater than the MIC, indicating these are bacteriostatic. These results indicate that the bactericidal and bacteriostatic activities of 1-4 are dependent on the bacterial strain. This behaviour is similar to standard anti-biotic, chloramphenicol which is considered bacteriostatic against most Gram-positive and many Gram-negative aerobic bacteria by binding to the 50S subunit of the bacterial 70S ribosome which causes inhibition of protein synthesis [54] . However, bactericidal activity on some bacteria, such as H. influenzae, S. pneumoniae and N. meningitidis, has also been reported which enables the use of chloramphenicol in the treatment of meningitis caused by the mentioned pathogens [55] . Similar variable bactericidal/bacteriostatic activities were also reported for related phosphanegold(I) dithiocarbamates [23] .
Disc diffusion and MIC are two standard assays used in the determination of anti-bacterial properties. The presence of a zone of inhibition indicates anti-bacterial potential and it is expected MIC tests would support the results. However, in this present study, a positive correlation was not observed for these two independent experiments. For instance, based on the MIC results, at 0.10 μg/mL, 4 was shown to be the most effective against S. epidermidis, but 4 only produced a 10 mm of zone of inhibition against S. epidermidis while the comparable result against S. pyogenes, with a MIC value of 0.78 μg/mL, has a zone of inhibition of 12 mm. Comparing the two assays, disc diffusion makes use of solid media while MIC uses liquid media. It is thought that the diffusion and mobility of the silver compounds in the solid medium is restricted, leading to poor diffusion through agar medium and thus moderate zones of inhibition are observed. Similar observations were made for related tin dithiocarbamates [50] .
Time kill assay
Time kill assays provide useful information to describe the pharmacodynamics of trial anti-bacterial compounds [56] . In contrast to MIC determinations, which involve the study of the anti-bacterial effect at one concentration after a specific time, the time kill assay Table 3 MIC (μg/mL) and MBC (μg/mL) of The presented MIC values are the lowest inhibitory concentrations obtained from three independent experiments conducted in triplicate.
Y.J. Tan et al. Journal of Inorganic Biochemistry 192 (2019) [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] investigates the effect of three different concentrations of 1-4, ½×, 1× and 2 × MIC, over a 24 h incubation period. According to CLSI protocols, a 3 log 10 CFU/mL or greater reduction in the viability of the bacterial colony relative to the initial inoculum is the point that differentiates between bactericidal and bacteriostatic activity [57] . The pharmacodynamics of 1-4 (Table 4 and Figs. 4-7) as well as chloramphenicol and tetracycline (Supplementary materials Table S1 and Figs. S7 and S8) against susceptible bacterial strains were determined using time kill assays; the standards were uniformly bacteriostatic against the tested bacteria.
As expected from the determined MBC/MIC ratios in Table 3 , the time kill assays for 1 and 2 toward E. faecalis and S. pneumoniae at 1 × MIC indicated they were bacteriostatic whereas toward S. epidermidis and S. pyogenes exhibited bactericidal behaviour. At 1 × MIC, 1 and 2 were bactericidal toward S. epidermidis after 1 h, and after 4 h toward S. pyogenes. At 2 × MIC, 1 was bactericidal toward S. epidermidis and S. pneumoniae after 1 h, and after 2 h for S. pyogenes. The latter result indicated 1 demonstrates rapid concentration-dependent bactericidal activity against S. pyogenes. Under the same conditions, 2 exhibited similar bactericidal effects as 1 toward S. epidermidis after 1 h at 2 × MIC. Compound 2 was also bactericidal toward S. pyogenes after 4 h at 2 × MIC. Therefore, the killing rate of 2 was slower than 1 against S. pyogenes.
The common feature of the time kill assays for 3 and 4 were that all were bactericidal against all bacteria with the notable exception of S. pneumoniae. Compound 3 demonstrated rapid concentration-dependent bactericidal activity against S. pyogenes. At 1 × MIC and 2 × MIC, bactericidal activity was achieved at 4 and 1 h, respectively, against S. pyogenes. By contrast, against E. faecalis, time to achieve 3 log 10 kill was similar at 1 × MIC and 2 × MIC. As a general observation, at 2 × MIC concentrations bactericidal effects were noted only after 4 h for E. faecalis and S. aureus (MRSA), 2 h for S. epidermidis and 1 h for S. pyogenes. Two of these, E. faecalis and S. pyogenes, were also susceptible at 1 × MIC after 4 h. For 4, the required time to achieve 3 log 10 kill was similar at 1 × MIC and 2 × MIC against E. faecalis, S. aureus (MRSA), S. epidermidis (all 2 h) and S. pyogenes (1 h) at both 1 × MIC and 2 × MIC concentrations.
The emergence of the multi-drug resistant bacterium, S. aureus (MRSA), is recognised as a serious health threat to the general public by the Centers for Disease Control and Prevention (CDC) as this rapidly develops resistance to new anti-biotics. In 2011, Vidaillac et al. [58] examined the in vitro activity of three anti-biotics commonly used in the treatment of S. aureus (MRSA) infections, namely oritavancin, vancomycin and teicoplanin. It was reported that oritavancin exhibited rapid bactericidal activity against S. aureus (MRSA) at 4 × MIC after 9 h exposure while both vancomycin and teicoplanin achieved a maximum 2.7 log 10 CFU/mL decrease against S. aureus (MRSA) at 8 × MIC. In the present study, the kill kinetic profile of 4 showed a far more rapid bactericidal activity i.e. within 2 h at 2 × MIC, compared to oritavancin. Also, 4 reached a maximum 5.2 log 10 CFU/mL decrease against S. aureus (MRSA) at 2 × MIC compared to vancomycin and teicoplanin. The killing rate of 4 was faster than 3 against S. aureus (MRSA) in which bactericidal activities were seen after 2 h to achieve a maximum 5.2 log 10 CFU/mL decrease at 2 × MIC. These results underscore the promising utility of 3 and 4 as anti-bacterial agents. Notably, all strains were found to regrow to the same or almost the same level as the control after 24 h at concentrations of 2×, 1× and ½ × MIC. This phenomenon is common in studies of bacterial killing rate of anti-microbial agents in time kill assays [59] . This may be due to two different sub-populations with different susceptibility in which the selective growing of resistant sub-population take over the preferential killing of susceptible sub-population at specified time of interaction [56] .
In summary, compounds 3 and 4 are demonstrated to be more effective anti-bacterial agents compared to 1, 2 and AgNO 3 . Silver nitrate, used in the synthesis of 1-4, is a known an anti-septic agent used in the prevention of eye infections in the new-born children and is known to be active against both Gram positive and Gram negative bacteria [8] . Considering the chemical structures, charge-neutral 3 and 4 are significantly bulkier than the salt due to the presence of the tricyclohexylphosphane and dithiocarbamate ligands. These characteristics ease the diffusion of the compounds across the bacterial membrane before they exhibit their anti-bacterial activity. The additional hydroxyl group (s) in 3 and 4 impart significant effects in the anti-bacterial activity as compared to 1 and 2, indicating that the ratio of hydrophobicity/hydrophilicity can be fine-tuned for the enhancement of in vitro antibacterial activity. To determine the lipophilicity and hydrophobic properties of the synthesised compounds, oil/water partition co-efficient (in term of logP) in systems such as octanol/water and chloroform/water can be further investigated [60] . The anti-bacterial activity of metal dithiocarbamates is suggested to arise by the inactivation of physiologically important enzymes [14, 61] . Thus, possible mechanisms of action of 1-4 can be verified by investigating their inhibition of enzymes such as SH-protease papain, NADP+-dependent alcohol dehydrogenase and the NAD+-dependent alcohol dehydrogenase [62] .
Cytotoxicity
The possible cytotoxic effects of 1-4 were investigated through a MTT assay conducted on a normal cell line, the HEK 293 human em- 
Conclusions
Four new binuclear phosphanesilver(I) dithiocarbamates, 1-4, have been characterised and investigated for their anti-bacterial potential. Based on MIC assays, 1-4 possess potent and selective anti-bacterial activity against Gram-positive pathogens; 1-4 are non-toxic to human embryonic kidney cells, HEK 293. Crucially, 3 and 4 are also potent against S. aureus (MRSA), which is resistant to several classes of antibiotics. While interesting selectivity is noted, 4, with low MIC values and more rapid bactericidal activity against S. aureus (MRSA), could provide clinical advantages in bacteriostatic therapy for immunocompromised patients by rapid elimination of S. aureus (MRSA) pathogens and thereby reduce the possibility of the spread of infection. Based on the time-kill studies, the concentrations required and bacterial killing rates of 1-4 were different from each other suggesting distinct mechanisms of action. In summary, the new compounds show great promise as effective anti-bacterial agents against Gram-positive bacteria. In particular, further investigations are warranted to determine the therapeutic potential of compound 4 against S. aureus (MRSA). 
